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Abstract: Orthopedic implants requiring osseointegration are often surface modified; however,
implants may shed these coatings and generate wear debris leading to complications. Titanium
nanotubes (TiNT), a new surface treatment, may promote osseointegration. In this study, in vitro
(rat marrow-derived bone marrow cell attachment and morphology) and in vivo (rat model of
intramedullary fixation) experiments characterized local and systemic responses of two TiNT surface
morphologies, aligned and trabecular, via animal and remote organ weight, metal ion, hematologic,
and nondecalcified histologic analyses. In vitro experiments showed total adherent cells on trabecular
and aligned TiNT surfaces were greater than control at 30 min and 4 h, and cells were smaller in
diameter and more eccentric. Control animals gained more weight, on average; however, no animals
met the institutional trigger for weight loss. No hematologic parameters (complete blood count with
differential) were significantly different for TiNT groups vs. control. Inductively coupled plasma mass
spectrometry (ICP-MS) showed greater aluminum levels in the lungs of the trabecular TiNT group
than in those of the controls. Histologic analysis demonstrated no inflammatory infiltrate, cytotoxic,
or necrotic conditions in proximity of K-wires. There were significantly fewer eosinophils/basophils
and neutrophils in the distal region of trabecular TiNT-implanted femora; and, in the midshaft of
aligned TiNT-implanted femora, there were significantly fewer foreign body giant/multinucleated
cells and neutrophils, indicating a decreased immune response in aligned TiNT-implanted femora
compared to controls.
Keywords: orthopedic; nanomedicine; nanomodified surfaces; animal model; immune response
1. Introduction
Titanium, both commercially pure and alloyed, has been used for decades in various
biologic environments, including orthopedic implant designs [1–4]. With a combination of
corrosion resistance, biocompatibility, mechanical properties approximating bone, and low
cost, titanium continues to be a common material for fracture plates and screws as well
as components requiring solid bone–implant fixation (e.g., knee arthroplasty tibial tray,
hip arthroplasty femoral stem) [1–4]. To promote osseointegration, macroscale coatings
have been applied to titanium implant surfaces via titanium plasma spray (TPS) as well as
hydroxyapatite (HA) coating or sintering for powder- or bead-based coatings [5–8]. These
coatings, however, are subjected to shear loads during surgical implantation, contact with
surgical tools, and eventually micromotion at the bone–implant interface in vivo [5–8].
These coatings may then separate from the substrate, generating third-body wear debris
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that increases mechanical wear of bearing surfaces. Additionally, local phagocytic cells en-
countering this debris may initiate a biologic cascade leading to periprosthetic osteolysis [9].
The body’s immune response to wear debris is dependent on particulate composition, con-
centration, and morphology and may result in periprosthetic joint infection, bone fracture,
catastrophic implant fracture, as well as osteoclastic bone resorption around the implant,
component loosening, and, ultimately, revision surgery [5,10,11].
Titanium nanotube (TiNT) surfaces, which are electrochemically etched from the
titanium implant substrate instead of applied as a coating, are an emerging technology that
may enhance osseointegration of orthopedic implants [12–17], although literature is scarce
regarding the in vivo immune response and toxicity to these nanostructured materials as
implantable devices [18,19]. Due to improved interfacial strength, decreased thickness, and
potential for more rapid osseointegration, TiNT surfaces may generate less third-body wear
particulate compared to current coating technologies; however, thorough characterization
of the immune and inflammatory response to new implantable materials is needed.
Two TiNT surface morphologies, termed aligned and trabecular, have been devel-
oped for orthopedic applications necessitating osseointegrative properties [17,20–22]. The
aligned TiNT morphology comprises arrays of vertically oriented nanotubes, while the
trabecular TiNT morphology exhibits a random surface resembling the three-dimensional
porous network of trabecular bone. In this study, local and systemic responses to aligned
and trabecular TiNT surfaces were assessed through in vitro cellular response on each
material as well as in vivo performance in a clinically relevant, rodent model of long-term
femoral intramedullary implant to simulate joint arthroplasty, including assessment of
longitudinal animal weights, remote organ weights, metal ion levels in remote organs and
whole blood, hematology, and nondecalcified histology [23,24]. Following on survivability
testing and finite element modeling indicating that compression and shear loading to the
TiNT surfaces were below yield failure strength, this study hypothesizes that TiNT sur-
faces will demonstrate equivalent local and systemic responses, equivalent to unmodified
titanium alloy substrate surfaces [22]. Further, we hypothesize that aligned and trabec-
ular TiNT surfaces yield comparable in vitro and in vivo results, as both morphologies
provide additional surface area for cell attachment as well as resultant bony ongrowth and
ingrowth.
2. Materials and Methods
2.1. Implant Fabrication
Samples for in vitro and in vivo studies were fabricated with titanium alloy (Ti-6Al-4V
ELI) sheet and wire (wire: Custom Wire Technologies, Inc., Port Washington, WI, USA),
respectively, using a well-established electrochemical anodization process (Appendix A—
Supplemental Methods, Figure A1) [17,21]. Following the initial etching process, aligned
TiNT surfaces were then ultrasonicated in deionized (DI) water for 2 minutes; however,
trabecular TiNT surfaces received no additional treatment (Figure 1). Control samples
were rinsed with DI water and air-dried. On average, inside diameter (ID) of individual
nanotubes was 60 nm and 1 µm length on aligned TiNT surfaces. Similarly, trabecular TiNT
surfaces contained a 1 µm layer of 60 nm ID aligned nanotubes, on average, covered with
an additional 1 µm of over-etched nanotubes. The over-etched layer mimics the porous
structure and topography of trabecular bone.
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Figure 1. Aligned titanium nanotubes (TiNT) (A) and trabecular TiNT (B) surfaces. (A,B) Scale 
Bar: 1 μm. 
2.2. In Vitro Experimentation to Assess Cell Attachment and Morphology 
Cells for all in vitro experiments were isolated from the intramedullary cavities of the 
femora of 14-week-old female Sprague Dawley rats (SD; Charles River Laboratories, Wil-
mington, MA, USA). Following isolation and culture using previously described methods, 
the plastic-adherent fraction of bone marrow cells (BMC) was collected and used for all 
subsequent experiments (Appendix A—Supplemental Methods, Figure A2) [17]. This cell 
population was selected for experimentation due to the potential of mesenchymal stem 
cells (MSC) to differentiate toward numerous cell types, including osteoblasts. 
Early cell attachment and morphology were compared between aligned TiNT, tra-
becular TiNT, and control surfaces, using three samples per group per timepoint (coupons 
sectioned from sheet: 10 mm x 10 mm; timepoints: 30 min, 2 h, 4 h) [15,25]. To increase 
attachment potential, all sample coupons were soaked in fetal bovine serum (FBS) for 30 
minutes prior to drop-seeding (density: 40,000 BMCs/coupon), followed by a 6 h incuba-
tion before adding the remaining volume of media and incubating overnight. At each 
timepoint, cells were fixed and stained with Actin Green (Actin Green 488 ReadyProbes 
Reagent, Life Technologies, Carlsbad, CA, USA) for cytoskeleton visualization and mor-
phology (1 drop stain; 40 min incubation) as well as 4’, 6-Diamidino-2-Phenylindole, di-
hydrochloride (DAPI; Life Technologies, Carlsbad, CA, USA) for nucleus visualization 
(0.5 mL stain; 20 min incubation). Following cell fixation, fluorescence imaging (IX71, 
Olympus America, Center Valley, PA, USA) was performed at thirteen standardized re-
gions of interest to quantify the total number of adherent cells, cell equivalent diameter, 
and cell eccentricity. Because all non-adherent cells were removed prior to imaging, Actin 
Green and DAPI also demonstrated cell adhesion to the surfaces. Environmental scanning 
electron microscopy (SEM; Vega3XMU, Tescan USA, Warrendale, PA, USA) was used to 
further document cell morphology; specifically, cells were fixed in 4% glutaraldehyde on 
coupons, and then coupon was sputter-coated with a thin layer of gold–palladium alloy. 
Samples were imaged at 20.0 kV and a magnification of 300×. Total cell number, cell equiv-
alent diameter, and cell eccentricity (measured using onboard microscope measurement 
tool) were statistically compared using a one-way analysis of variance (ANOVA) model, 
with a Tukey post-hoc test and α = 0.05. 
2.3. In Vivo Experimentation to Assess Biologic Response to Nanotube Surfaces 
After preparing titanium alloy Kirschner wires (K-wire; Custom Wire Technologies, 
Inc., Port Washington, WI; USA, material: Ti6Al4V ELI Hard, diameter: 1.25 mm, single 
trocar tip for insertion), aligned TiNT-etched, trabecular TiNT-etched, or unetched tita-
nium (control) K-wire implants (n = 6 per group) were inserted retrograde into the femoral 
intramedullary canals of SD rats for a single, long-term endpoint of 12 weeks [24,26,27]. 
Three naïve/nonoperative animals were housed for the same duration, in order to estab-
lish baseline characteristics. Treatment groups were randomized just prior to surgery by 
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2.2. In Vitro Experimentation to Assess Cell Attachment and Morphology
C lls for all in vitro experiments were isolated from the intramedullary cavities of the
femora of 14-week-old female Sprague Dawley rats (SD; Charles River Laboratories, Wilm-
ington, MA, USA). Following isolation and culture using previously described methods,
the plastic-adherent fraction of bone marrow cells (BMC) was collected and used for all
subsequent experiments (Appendix A—Supplemental Methods, Figure A2) [17]. This cell
population was selected for experimentation due to the potential of mesenchymal stem
cells (MSC) to differentiate toward numerous cell types, including osteoblasts.
Early cell attachment and morphology were compared between aligned TiNT, trabec-
ular TiNT, and control surfaces, using three samples per group per timepoint (coupons
sectioned from sheet: 10 mm × 10 mm; timepoints: 30 min, 2 h, 4 h) [15,25]. To increase
attachment potential, all sample coupons were soaked in fetal bovine serum (FBS) for
30 min prior to drop-seeding (density: 40,000 BMCs/coupon), followed by a 6 h incubation
before adding the remaining volume of media and incubating overnight. At each timepoint,
cells were fixed and stained with Actin Green (Actin Green 488 ReadyProbes Reagent,
Life Technologies, Carlsbad, CA, USA) for cytoskeleton visualization and morphology
(1 drop stain; 40 min incubation) as well as 4’, 6-Diamidino-2-Phenylindole, dihydrochlo-
ride (DAPI; Life Technologies, Carlsbad, CA, USA) for nucleus visualization (0.5 mL stain;
20 min incubation). Following cell fixation, fluorescence imaging (IX71, Olympus America,
Center Valley, PA, USA) was performed at thirteen standardized regions of interest to
quantify the total number of adherent cells, cell equivalent diameter, and cell eccentricity.
Because all non-adherent cells were removed prior to imaging, Actin Green and DAPI also
demonstrated cell adhesion to the surfaces. Environmental scanning electron microscopy
(SEM; Vega3XMU, Tescan USA, Warrendale, PA, USA) was used to further document
cell morphology; specifically, cells were fixed in 4% glutaraldehyde on coupons, and then
coupon was sputter-coated with a thin layer of gold–palladium alloy. Samples were imaged
at 20.0 kV and a magnification of 300×. Total cell number, cell equivalent diameter, and
cell eccentricity (measured using onboard microscope measurement tool) were statistically
compared using a one-way analysis of variance (ANOVA) model, with a Tukey post-hoc
test and α = 0.05.
2.3. In Vivo Experimentation to Assess Biologic Response to Nanotube Surfaces
After preparing titanium alloy Kirschner wires (K-wire; Custom Wire Technologies,
Inc., Port Washington, WI; USA, material: Ti6Al4V ELI Hard, diameter: 1.25 mm, single
trocar tip for insertion), aligned TiNT-etched, trabecular TiNT- tched, r un tched titanium
(co tr l) K-wire impl nts (n = per group) were ins rted retrograde into the femoral
intramedullary canals of SD rats for a single, long-term endpoin of 12 weeks [24,26,27].
Three naïve/nonoperative animals ere housed for he sam dura ion, in der to establish
baseline characteristics. Treatment groups were randomiz d just prior to surgery by
nonoperative staff. Rats receiv daily veterinary care to identify complications and
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were weighed weekly; at endpoint, hematologic, metal ion, and histologic analyses were
performed.
2.4. Surgical Procedure for Unilateral Intramedullary Implantation
Under an Institutional Animal Care and Use Committee (IACUC)-approved protocol,
14-week-old, female SD rats underwent unilateral femoral implants via retrograde insertion.
After anesthetization, rats were placed supine on a sterile, heated operating table with
the knee in maximum flexion. Following final sterile preparation, a lateral–patellar skin
incision allowed access to the distal femur. After drilling a shallow, pilot hole in the
intercondylar groove, a K-wire was inserted into the intramedullary canal to the greater
trochanter (proximal femur). Placement of the implant was confirmed via fluoroscopy.
The K-wire was then clipped and recessed at the insertion site, followed by closure of
arthrotomy and skin incisions with appropriate suture materials. Animals were then
recovered and allowed ad libitum activity under endpoint.
2.5. Postoperative Care and Health Assessments
All rats were evaluated daily for clinical signs of complications and overall health,
including pain level, activity level, and food/water consumption. Rats were weighed
preoperatively and weekly throughout the experiment. At endpoint, remote organs were
collected and weighed, as another assessment of animal health. A one-way ANOVA model
was used to compare longitudinal animal weights and endpoint organ weights between
treatment groups, with α = 0.05.
2.6. Hematologic Analysis
At endpoint, each anesthetized rat underwent antemortem cardiac puncture to collect
blood for hematologic analyses (CBC; complete blood count with differential) to quantify
the following thirteen parameters associated with either systemic inflammation/infection
or anemia status: white blood cell count (WBC), lymphocyte concentration (Lymph),
monocyte concentration (Mono), granulocyte concentration (Gran), hematocrit (HCT),
mean cell volume of red blood cells (MCV), red blood cell distribution width (RDWa),
hemoglobin concentration (Hgb), mean cell hemoglobin concentration (MCHC), mean cell
hemoglobin (MCH), red blood cell count (RBC), total platelet count (PLT), and mean and
platelet volume (MPV) (HemaTrue Hematology Analyzer, Heska, Loveland, CO, USA).
Blood was collected in vacutainer tubes with Ethylenediaminetetraacetic acid (EDTA) and
immediately processed. A one-way ANOVA model was used to compare hematologic
parameters between treatment groups, with α = 0.05.
2.7. Metal Ion Analysis of Whole Blood and Remote Organs
Inductively coupled plasma mass spectrometry (ICP-MS; HP 4500, Agilent Technolo-
gies, Santa Clara, CA, USA) was used to measure the titanium, aluminum, and vana-
dium concentrations in each remote organ and a whole blood sample from each animal
(Appendix A—Supplemental Methods). ICP-MS calibration was performed using both
ASTM standards of each target element as well as non-implanted samples of the rods
from each testing condition. At endpoint, remote organs (i.e., spleen, liver, lungs, kidneys,
brain) were harvested, weighed, and stored (4 ◦C in ultra-low leachable sample tubes) until
analysis. Samples were analyzed in tandem with a laboratory reagent blank and duplicate
laboratory fortified blanks to quantify background metal levels as well as process accuracy
and precision, respectively. A one-way analysis of variance model was used to compare
metal ion levels between treatment groups, with α = 0.05.
2.8. Nondecalcified Histologic Analysis
At study endpoint, implanted femora were also harvested for nondecalcified histologic
analysis. Femora from each animal were stripped of soft tissues and 10% zinc-buffered
formalin for 96 h, followed by three rinses in phosphate buffered saline, and 70% ethanol
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storage to prepare for histologic processing. Femora were subsequently embedded in
methyl methacrylate, then ground and polished longitudinally to the approximate center of
the implant, followed by cutting and applying one 5 µm thick section to a slide. Each slide
was stained with Stevenel’s Blue and van Gieson picrofuchsin (SBVG) for visualization of
presence of immune-related cellular activity. SBVG is a widely-used stain to assess bone
formation, due to visualization of both mature bone and osteoid as well as fibrous tissue,
which may signify inferior osseointegration and/or increased inflammatory response,
especially at the bone–implant interface [28–30]. Stained sections were manually scanned
at a magnification of 20× to facilitate both high-magnification and whole-mount analyses
(90i, Nikon Instruments, Inc., Melville, NY, USA). Three 20× regions of interest (ROI) per
location (i.e., distal, midshaft, proximal) per section were captured. Within each ROI, five
cell types were identified: foreign body giant (FBG)/multinucleated cell, granulocyte (non-
neutrophilic, including eosinophils and basophils), neutrophil, monocyte, and lymphocyte.
Cell constituents within each ROI were then graded on a scale of 0 to 2, with 0 = cells
comprising 0–25% of the field, 1 = cells comprising 25–50% of field, and 2 = cells comprising
greater than 50% of field. For FBG/multinucleated or granulocyte, a Grade 2 was defined
as three or more cells per field. Grades were statistically compared between TiNT groups
and control, using a Mann–Whitney rank sum test, with α = 0.05.
3. Results
3.1. In Vitro Experimentation to Assess Cell Attachment and Morphology
DAPI staining indicated that cells were viable and adhered on both the TiNT and
control surfaces at the three early timepoints of 0.5, 2, and 4 h (Figure 2). The total number
of adherent cells was significantly greater on the TiNT surfaces than on control surfaces,
demonstrating more rapid cell attachment on both TiNT surfaces compared to control
(Figure 3); specifically, total adherent cells on trabecular TiNT and aligned TiNT surfaces
were significantly greater than control at 0.5 h (p = 0.014 and p = 0.018, respectively) and
4 h (p = 0.008 and p = 0.044). Over the 3.5-hour period, the number of cells increased
on all surfaces, and the total number of adherent cells was equivalent or slightly greater
on trabecular TiNT surfaces compared to aligned TiNT surfaces. Analysis of total cell
count was unfeasible at later timepoints (3, 7, 14, 21 days) due to cell coalescence or
superimposition. Actin Green staining showed active cell spreading on TiNT and control
surfaces at all timepoints (Figure 2).
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Figure 2. Representative fluorescent images of dihydrochloride (DAPI)-stained (A) and Actin Green-stained (B) aligned
TiNT, trabecular TiNT, and control surfaces at three early timepoints, 0.5 h, 2 h, and 4 h.
At the 2- and 4-h timepoints, increased spreading was observed on TiNT surfaces
compared to control surfaces. Additional imaging via SEM showed differential cell mor-
Nanomaterials 2021, 11, 583 6 of 17
phology patterns as a function of sample topography (Figure 4). On the TiNT surfaces,
cells exhibited a globular shape, compared to the elongated, fibrillar cell morphology on
control surfaces.
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Subsequent analysis of cell morphology images yielded cell equivalent diameter and
eccentricity (Figure 3). Quantification of the cell equivalent diameter indicated that BMC on
the TiNT surfaces were smaller (in diameter) than BMC on control surfaces. The discrepancy
in cell diameter was significant between trabecular TiNT and aligned TiNT surfaces versus
control at 0.5 h (p = 0.031 and p = 0.048, respectively). At the 2-hour timepoint, there was
a significant difference in diameter between only the aligned TiNT and control surfaces
(p = 0.008). At 4 h, the difference diameter was significant for between both trabecular
TiNT and aligned TiNT, compared to control (both p = 0.003). Cells on the TiNT surfaces
had significantly greater eccentricity than on the control surfaces, with cells on aligned
TiNT demonstrating the greatest eccentricity (Figure 3). At 0.5 h, there was a significant
difference in eccentricity between the trabecular TiNT and aligned TiNT, compared to
control (p = 0.007 and p = 0.004, respectively). There was a significant difference between
both the trabecular TiNT and aligned TiNT groups versus control again at 2 h (p = 0.003
and p < 0.001, respectively). There were no significant differences in eccentricity between
groups at the 4-hour timepoint.
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num, or vanadium levels compared to control. Histologic analysis demonstrated a lack of 
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After weighing each organ, metal conce trations were asses ed (Figure 6). Aluminu
levels in the lungs were significantly greate in the trabecular TiN group compared to
control (p = 0.022). No other organs exhibited significantly increased titanium, alumin ,
or vanadium levels compared to control. Hist logic analysis demonstrated a lack of inflam-
matory infilt ate in proximity to the nails within the intram dull ry space, for all groups
(Table 3; App ndix A—Supplemental Results, Table A1). There wer significantly fewer
granulocytes and neutrophils in the distal ROI of the femora implanted with trabecular
TiNT-etched implants (p = 0.040 and p = 0.019, respectively). In the midshaft ROI, there
were significantly fewer foreign body giant/multinucleated cells and neutrophils in the
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aligned TiNT group (p = 0.039 and p = 0.019, respectively). There were no observed necrotic
or cytotoxic events observed within the marrow cavity of any of the animals (Figure 7).
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Giant/Multinucleated Granulocyte Neutrophil Monocyte Lymphocyte
Distal
Trabecular TiNT 0.126 0.040 0.019 0.720 0.391
Aligned TiNT 0.287 0.476 0.345 0.720 0.260
Midshaft
Trabecular TiNT 0.142 0.603 1.000 0.314 0.982
Aligned TiNT 0.039 0.682 0.019 0.736 0.260
Proximal
Trabecular TiNT 0.527 0.646 0.345 0.652 0.871
Aligned TiNT 0.939 0.219 0.345 0.747 0.314
* Bolded p-values indicate significant results; ROI = region of interest.
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trabecular TiNT (B), and (C) control K-wires.
4. Discussion
Local and systemic responses to aligned and trabecular TiNT surfaces were evaluated
via an in vitro study focused on cell morphological and attachment behavior, followed by
a clinically relevant in vivo study of biologic response to implant materials. The in vivo
study included multiple characterization methods, including a general health assessment
(e.g., body weight) as well as hematologic, metal ion, and histologic analyses.
DAPI and Actin Green staining demonstrated cell attachment and spreading from
0.5 h through 21 days on all surfaces, an indication of the suitable environ ent of both
TiNT surfaces and control. Total cell counts were greater on TiNT surfaces compared to
unetched controls at the three early timepoints, which corresponds with current reports
of more rapid cell attachment on nanotube surfaces [31–33]. Additionally, the diameter of
BMC on TiNT surfaces was smaller compare to cells seeded ont controls, and cells on
TiNT surfaces were more eccentric than cells on controls. These data correspond with SEM
imaging of attached BMC, which howed a rounded cell morph logy on TiNT surfaces
and fibrillar-shaped cells on control surfaces. The diameter, eccentricity, and imaging
findings may be indic tive of cell develo ment in different planes o the T NT surfaces
ompared to cont ols. Shokuhfar et al. sectioned TiNT arrays see ed with osteoblasts
(MC3T3-E1; mouse osteoblasts) a d observed cell attachment on nanotube arrays as well
as cell filopodia stre ching downw rd into the hollow p r ion of individual nanotubes [20];
therefore, differences in cell morphologic behavior between groups may be explained by
t e BMC i teraction with TiNT surfaces, as the BMC exte d into nano ubes and voids
within the array, instead of across th top of the surface. Rangamani et al. performed
modeling of cell shapes and determined that greater cell eccentricity was associated with
enhanced signal modulation due to temporary collections of activated receptors in sections
of greater curvature of cells, specifically in gro th factor receptor pat ways; therefore,
greater cell eccentricity on nanotube surfaces may demonstrate amplified signals resulting
in downstream effects, such as bone formation [34].
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In the in vivo study, there were several significant differences in body weight between
groups at two weeks during the experiment; however, the body weights recovered were
not an established trend, and no interventions were required at any time for weight loss.
At endpoint, remote organ masses were compared between groups, and these also showed
no significant difference. Despite increased concentrations of aluminum, titanium, and
vanadium in the aligned TiNT and trabecular TiNT wires versus control wires, only alu-
minum levels were significantly increased in the lungs of the rats implanted with trabecular
TiNT-etched wires compared to controls. No other organs or whole blood samples showed
significantly elevated metal levels, when the experimental groups were compared to con-
trol. A study of intraarticular injection of TiO2 nanoparticles (45 nm average diameter; 0.2,
2, 20 mg/kg TiO2 in suspension) into rat knee joints showed nanoparticle migration to
remote organs as well as pathologic changes in the heart, lung, liver, and knee at 7 days
post-injection [35,36]. Although our study showed metal ion concentration in remote
organs via ICP-MS and did not histologically assess remote organs, we theorize that the
amount of TiO2 particulate debris shed in the rat femora was likely less than 0.2 mg/kg.
At study endpoint, no hematologic markers of white and red blood cell function, which
would signal systemic inflammation-, infection-, or anemia-related complications, were
significantly elevated in the experimental groups compared to control. Histologic analysis
showed several significant differences in cell populations between the TiNT groups and
control, with less foreign body giant/multinucleated, eosinophil/basophil, and neutrophil
cell activity in TiNT-implanted femora than control. There were no significant differences
between monocyte and lymphocyte activity.
In in vitro and in vivo studies of vascular toxicity, Bayat et al. established that titanium
nanotubes with 30 nm diameter as well as ultra-small TiO2 nanoparticles (1−3 nm) were
not cytotoxic, and nanoparticles did not possess oxidative potential [37]. In vivo studies
in rat models have also shown that TiO2 nanoparticles are not genotoxic [38,39]. Neacsu
et al. showed that after seeding murine macrophages onto TiNT and unetched titanium
surfaces under pro-inflammatory and standard conditions, inflammatory activity related
to cytokine and chemokine gene expression, foreign body giant cell products, and nitric
oxide release all decreased on TiNT surfaces but not on unetched controls; therefore, the
authors suggested that the TiNT surfaces may regulate macrophage response, thereby
diminishing the overall inflammatory cascade [40]. Studies by Ostberg et al. and Latha
et al., using models of leukocyte-seeded TiNT surface and mixed lymphocyte reaction
(MLR), respectively, concurred with these findings [41,42]; specifically, Latha et al. showed
a 30–35% suppression of splenocyte proliferation of titanium nanotubes (H2Ti3O7) [42].
Assessing hemocompatbility, Smith et al. showed increased adsorption of blood serum
protein, platelet adhesion and activation, and clotting of whole blood as well as no evi-
dence of monocyte activation and cytokine secretion on TiNT surfaces versus control [43].
Radizun et al. showed that aluminum nanoparticles, in concentrations up to 400 µg/mL,
have no significant toxic effect on mammalian cell viability, and Alshatwi et al. found
human MSC cytotoxicity via Al2O3 nanoparticles at 40 µg/mL; in this study, aluminum
content in all specimens was substantially below this threshold (maximum aluminum
content within range of standard deviation; Figure 6: 4.24 µg/mL) [44,45]. In a clinical,
in vivo study, Swiatkowska et al. described titanium levels ranging between 2.20 and
2.56 µg/L in blood and plasma, measured via ICP-MS, in well-functioning unilateral hip
implants, indicating some level of titanium may be tolerable by patients, without eliciting
a whole-body response [46].
Study limitations included difficulties with staining TiNT surfaces, especially at time-
points greater than 4 h. Because of the nanotopography and voids, which were ideal for
cell attachment, stain penetration of the cells was complicated and incomplete. While three
naïve animals were included to assess background metal levels, inclusion of additional
animals may have been beneficial to further study and quantify these levels. Addition-
ally, a full assessment of metal levels of animal food, bedding, enrichment materials, etc.
may have allowed further reduction and elimination of background aluminum, titanium,
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and vanadium levels in all animals [47,48]. Based on the results of this study, a full sys-
tematic characterization of this material’s biocompatibility and toxicity properties should
be conducted in accordance with applicable standards, such as ISO 10993-11 (Biological
Evaluation of Medical Devices—Part 11: Tests for Systemic Toxicity).
5. Conclusions
Previous studies have demonstrated the biocompatibility of TiNT surfaces and cor-
respond with the findings of this study showing TiNT surfaces support cell attachment
and proliferation and do not initiate systemic effects in an in vivo model of intramedullary
implantation. The presented in vitro data demonstrated that cells cultured on bare TI6Al4V
surfaces were spindle shaped, while those cultured on TiNT surfaces demonstrated a more
rounded appearance, which may confer benefit with respect to in vivo bone formation.
In vivo data demonstrated that the accumulation of metal ions in filtering organs was
largely similar between the two morphologies of TiNT surfaces and control bare Ti6Al4V
surfaces, aside from an increased aluminum concentration in the lungs of rats with aligned
TiNT implants. This increased aluminum concentration in lung specimens was not asso-
ciated with alterations in overall health of the animal or observed pathology. As such,
it can be concluded that at the time points studied, metal accumulation associated with
TiNT surfaces was similar to control surfaces, and no systemic or local complications were
observed in TiNT- or control-implanted animals.
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Appendix A. Supplemental Methods and Results
Appendix A.1. Titanium Nanotube-Etched Specimen Fabrication
Titanium nanotube-etched specimens were prepared for in vitro and in vivo experi-
ments, based on previous methods developed and tested by our group [17,20–22]. Titanium
alloy (Ti-6Al-4V ELI) sheet (in vitro experiments) or wire (in vivo study) were polished
with 600 grit abrasive sheet and deionized (DI) water, then rinsed in DI water and air-dried.
All sample materials were cleaned with acetone just prior to etching, followed by air drying.
On wire samples, the trocar tip was coated to prevent nanotube formation on the site of
insertion. To etch, samples (sheet or wire) were suspended vertically toward one side of a
glass beaker and then connected as the anode to a variable DC power supply. Additionally,
in the beaker, a small diameter graphite rod was suspended, diametrically opposed to the
sample, and connected to ground (cathode). An electrolyte solution (98 vol.% ethylene
glycol, 2 vol.% deionized water, and 0.6 wt.% NH4F) was added to the beaker, with a
final volume just below the electrical connections to the sample and graphite. Before
adding NH4F to the electrolyte solution, it was first completely dissolved in DI water;
following this addition, the electrolyte solution was mixed to ensure all constituents were
fully combined. Then, the power supply was engaged (+60 VDC) and etching was allowed
to proceed for 40 minutes. After etching, the power supply was disengaged and sample(s)
were immediately removed from the beaker, followed by a 1-minute rinse under DI water
and air drying. After drying, the coating on each trocar tip was removed after etching
and sonication (aligned TiNT samples were sonicated for 2 min; trabecular TiNT samples
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were not sonicated). Sheet samples were then sectioned into coupons (10 mm × 10 mm);
wires were net-shape and did not require sectioning. To convert the amorphous titania
oxide layer to the crystalline anatase phase, which increases the hydrophilicity of the
TiNT surfaces, samples were placed in a programmable annealing oven. The temperature
was increased by 7.5 ◦C per minute to a steady state of 450◦C for a total heating time of
three hours. Samples were removed after the oven was completely cooled, which was
approximately 5 h. Specimens were stored in cushioned, sealed storage cases until use
(Figure A1).
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Figure A1. Digital photographs showing the final appearance of 10 mm × 10 mm coupon samples
(top) and Kirschner wires (bottom). TiNT-etched surfaces appear golden and smooth, compared to
unmodified control surfaces.
Appendix A.2. In Vitro Experimentation to Assess Adherent Cell Count, Cell Equivalent Diameter,
and Cell Eccentricity
Rat bone marrow cells (BMCs) were used for all in vitro experimentation, with cell
harvest and preparation conducted based on previously developed laboratory protocols by
our group [49]. To obtain BMCs, rats were euthanized via CO2 asphyxiation, and then each
femur and tibia were aseptically harvested. After removing both the proximal and distal
ends of each bone, marrow cavities were flushed with warm, sterile phosphate-buffered
saline. Whole bone marrow was plated (T-25 culture flasks) and cultured (37 ◦C and 5%
CO2) in a sterile, copper-lined CO2 incubator. Non-adherent cells were removed after 24 h
of incubation via thorough rinsing with warm, sterile saline. Then, the plastic-adherent
fraction of bone marrow cells (BMCs), an enriched source of mesenchymal stem cells (MSC)
capable of differentiating toward numerous cell types, was obtained.
For in vitro experimentation, sample coupons were placed into individual wells of
12-well polystyrene culture plates and soaked in fetal bovine serum (FBS) for 30 min prior
to seeding to increase attachment. at s (P2-3; density = 40,000 cells per coupon;
suspended in 50 µL of media) w re drop-seeded on each sample and incubated (37 ◦C
and 5% CO2) for 6 h before adding the remaining volume of media (D EM; Dulbecco’s
Modified Eagle Medium; suppl mentation = 10% fetal bovine serum, and 1% penicillin-
streptomycin). Incubation (same conditions) continued for an additional 20 h to ensure
attachment. Following incubation, fluorescence imaging at 13 standardized regio s of
interest per coupon was performed, approximately 70% of the specimen surface, followed
by subsequent quantification of (Figure A2).
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Appendix A.3. Metal Ion Analysis of Remote Organs and Whole Blood
Inductively coupled plasma mass spectrometry (ICP-MS; HP 4500, Agilent Technolo-
gies, Santa Clara, CA) was performed to quantify aluminum, titanium, and vanadium
content in whole-blood and remote organ samples. Sample tubes, made of ultra-low leach-
able material to avoid metal contamination, were labeled and weighed to three significant
figures before sample collection. At endpoint, whole blood (≥2 mL) was collected, before
proceeding with dissection of re ote organs (i.e., spleen, liver, lungs, kidneys, brain).
Organs were weighed before being placed i t t es, a eac filled sample tube was
weighed again to determine the actual/net weight of the collected specimen.
All samples were transported and held on ice (~4 ◦C) until analysi . Samples were
digested to dis olve the metals into an aqueous solution by placing a combination of
highly pure solutions of nitric acid, hydrochloric acid, hydrogen peroxide, and water into
the tubes. The tubes were heated at 95 ◦C for 2 h per cycle. Some of the samples went
through multiple digestion cycles for thorough digestion. For ICP-MS analysis, samples
were included in analytical batches of 20 samples, which includes a laboratory reagent
blank (LRB) t reference to the laboratory background value, laboratory
fortified blank (LFB) to measure accuracy of the analytical procedure, and a duplicate LFB
to measure the prec sion of the analytical procedure. The final volume of digestion was
set to 40 mL per specimen digested, and the digested solutions w re further diluted by
10 times and analyzed for aluminum, titanium, and v nadium contents using a standard
operating procedure (UL SOP# 14) based on the EPA guidelines (Method 2 0.8).
The total weight of each metal per specimen and concentration of each metal in a
specimen were recorded; weights and concentrations were reported to three significant
figures. Accuracy and precision data as part of the quality control carried through the
analytical batches ere also docu ented. Chain of custody forms containing sample
descriptions, sampling dates, etc. were completed and retained.
Appendix A.4. Histologic Analysis of Bone-Implant Interface
Average cell count data of five cell types (foreign body giant/multinucleated, granu-
locyte, neutrophil, monocyte, lymphocyte) for the three implant groups (trabecular TiNT,
aligned TiNT, control) in the three regions of interest (ROI; distal, midshaft, and proximal
femora) have been provided (Table A1).
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Table A1. Average histologic grade for three regions of interest in each treatment group *.
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the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells. Toxicol. Vitr. 2011, 25, 1694–1700. [CrossRef]
[PubMed]
45. Alshatwi, A.A.; Subbarayan, P.V.; Ramesh, E.; Al-Hazzani, A.A.; AlSaif, M.A.; Alwarthan, A.A. Al2O3Nanoparticles Induce
Mitochondria-Mediated Cell Death and Upregulate the Expression of Signaling Genes in Human Mesenchymal Stem Cells. J.
Biochem. Mol. Toxicol. 2012, 26, 469–476. [CrossRef] [PubMed]
46. Swiatkowska, I.; Martin, N.G.; Henckel, J.; Apthorp, H.; Hamshere, J.; Hart, A.J. Blood and plasma titanium levels associated
with well-functioning hip implants. J. Trace Elements Med. Biol. 2020, 57, 9–17. [CrossRef]
47. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Aluminum; Department of Health and Human
Services, Public Health Service: Atlanta, GA, USA, 2008.
48. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Vanadium; Department of Health and Human
Services, Public Health Service: Atlanta, GA, USA, 2012.
49. Maerz, T.; Fleischer, M.; Newton, M.D.; Davidson, A.; Salisbury, M.; Altman, P.; Kurdziel, M.D.; Anderson, K.; Bedi, A.; Baker, K.C.
Acute mobilization and migration of bone marrow-derived stem cells following anterior cruciate ligament rupture. Osteoarthritis
Cartilage 2017, 25, 1335–1344. [CrossRef]
